NASDAQ:MYOS - Nasdaq -
1.01
-0.12 (-10.62%)
The current stock price of MYOS is 1.01 null. In the past month the price decreased by -14.46%. In the past year, price decreased by -34.25%.
MYOS RENS Technology Inc. is a BioNutrition and BioTherapeutics company which focused on the discovery, development and commercialization of products which improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS RENS Technology Inc., formerly known as MYOS Corporation, is based in Cedar Knolls, New Jersey.
Myos Rens Tech
45 HORSEHILL ROAD SUITE 106
CEDAR KNOLLS NJ 07927
CEO: Joseph Mannello
Phone: 973-509-0444
The current stock price of MYOS is 1.01 null. The price decreased by -10.62% in the last trading session.
The exchange symbol of Myos Rens Tech is MYOS and it is listed on the Nasdaq exchange.
MYOS stock is listed on the Nasdaq exchange.
Myos Rens Tech (MYOS) has a market capitalization of 12.31M null. This makes MYOS a Nano Cap stock.
Myos Rens Tech (MYOS) has a support level at 0.91 and a resistance level at 1.1. Check the full technical report for a detailed analysis of MYOS support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MYOS does not pay a dividend.
Myos Rens Tech (MYOS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
ChartMill assigns a fundamental rating of 3 / 10 to MYOS. Both the profitability and financial health of MYOS have multiple concerns.
Over the last trailing twelve months MYOS reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 8.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -245.38% | ||
ROA | -110.91% | ||
ROE | N/A | ||
Debt/Equity | 0.15 |